Teva Pharmaceutical Industries
TEVA
#1188
Rank
$14.62 B
Marketcap
$13.05
Share price
0.38%
Change (1 day)
31.02%
Change (1 year)

P/E ratio for Teva Pharmaceutical Industries (TEVA)

P/E ratio as of February 2024 (TTM): -6.53

According to Teva Pharmaceutical Industries's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -6.525. At the end of 2022 the company had a P/E ratio of -4.30.

P/E ratio history for Teva Pharmaceutical Industries from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-4.30-120.41%
202121.1-895.1%
2020-2.65-75.11%
2019-10.760.27%
2018-6.65470.31%
2017-1.17-100.23%
20165181351.64%
201535.7122.07%
201416.1-39.88%
201326.761.01%
201216.627.88%
201113.0-7.39%
201014.0-42.88%
200924.5-53.9%
200853.2190.79%
200718.3-62.32%
200648.695.33%
200524.9-56.71%
200457.4160.23%
200322.1-11.42%
200224.9-15.12%
200129.3

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
27.5-521.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
14.8-327.00%๐Ÿ‡บ๐Ÿ‡ธ USA
15.0-330.35%๐Ÿ‡ซ๐Ÿ‡ท France
71.0-1,187.46%๐Ÿ‡บ๐Ÿ‡ธ USA
32.3-595.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
12.0-284.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
20.7-417.21%๐Ÿ‡ฎ๐Ÿ‡ณ India

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.